CULLETTA, Giulia
 Distribuzione geografica
Continente #
EU - Europa 1.558
NA - Nord America 1.442
AS - Asia 1.178
SA - Sud America 215
AF - Africa 34
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 4.445
Nazione #
US - Stati Uniti d'America 1.403
IT - Italia 589
RU - Federazione Russa 441
SG - Singapore 386
CN - Cina 270
BR - Brasile 159
VN - Vietnam 123
HK - Hong Kong 110
PL - Polonia 89
FR - Francia 78
DE - Germania 73
GB - Regno Unito 62
JP - Giappone 59
FI - Finlandia 51
IN - India 49
AT - Austria 27
BD - Bangladesh 26
NL - Olanda 26
TR - Turchia 26
ES - Italia 24
AR - Argentina 23
BE - Belgio 20
IL - Israele 18
MX - Messico 18
IE - Irlanda 17
CH - Svizzera 16
IQ - Iraq 16
KR - Corea 16
IR - Iran 14
RO - Romania 14
AU - Australia 12
CA - Canada 12
PK - Pakistan 12
SA - Arabia Saudita 12
UA - Ucraina 11
EC - Ecuador 7
PY - Paraguay 7
VE - Venezuela 7
ZA - Sudafrica 7
CO - Colombia 6
ID - Indonesia 6
SE - Svezia 6
UZ - Uzbekistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
PT - Portogallo 5
CI - Costa d'Avorio 4
EG - Egitto 4
JM - Giamaica 4
MA - Marocco 4
MY - Malesia 4
NG - Nigeria 4
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
PH - Filippine 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
OM - Oman 1
QA - Qatar 1
SL - Sierra Leone 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.445
Città #
Singapore 264
Palermo 220
Ashburn 204
San Jose 165
Chandler 100
Hong Kong 100
Moscow 73
Zgierz 70
New York 56
Ann Arbor 49
Fairfield 49
Ho Chi Minh City 49
Rome 44
Helsinki 43
Los Angeles 43
Beijing 41
Council Bluffs 41
Tokyo 35
Hefei 32
Lauterbourg 31
The Dalles 28
Wilmington 27
Hanoi 26
Dallas 24
Seattle 24
Partanna 22
Corciano 21
Woodbridge 21
Medford 18
Perugia 18
Buffalo 17
Dublin 17
Houston 17
Milan 17
São Paulo 16
Frankfurt am Main 15
London 15
Cefalù 14
Santa Clara 14
Tel Aviv 14
Des Moines 13
Princeton 12
Vienna 12
Barcelona 11
Hyderabad 11
Messina 11
Orem 11
Brussels 10
Chennai 10
Nuremberg 10
Philadelphia 10
Warsaw 10
Ludwigshafen am Rhein 9
San Diego 9
Birmingham 8
Boardman 8
Lawrence 8
Mexico City 8
Naples 8
Cambridge 7
Da Nang 7
Nanjing 7
Napoli 7
Osaka 7
Phoenix 7
Redwood City 7
Riyadh 7
Atlanta 6
Biên Hòa 6
Brooklyn 6
Catania 6
Guangzhou 6
Hoover 6
Istanbul 6
Lappeenranta 6
Montreal 6
Mumbai 6
Rio de Janeiro 6
Sydney 6
Altamura 5
Belo Horizonte 5
Bexley 5
Chicago 5
Jeddah 5
New Delhi 5
Redondo Beach 5
Stockholm 5
Tashkent 5
Zurich 5
Athens 4
Aversa 4
Basingstoke 4
Baton Rouge 4
Buenos Aires 4
Chevy Chase 4
Columbus 4
Daejeon 4
Eindhoven 4
Goiânia 4
Hérouville-Saint-Clair 4
Totale 2.505
Nome #
Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies 237
A comprehensive computational analysis of NR2F2/6 receptors for drug repurposing 229
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri 228
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs) 197
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 194
NEW TRANSLATIONAL READTHROUGH INDUCING DRUGS RESCUING NONSENSE MUTATED TP53: STRATEGIES AGAINST CANCER 178
Potential translational readthough inducin drugs: an optimized design and synthesis of new chemical scaffolds 172
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings 168
Investigating the inhibition of FTSJ1 a tryptophan tRNA-specific 2’-O-methyltransferase by NV TRIDs, as a mechanism of readthrough in nonsense mutated CFTR 163
Design of small molecules and identification of putative anticancer therapeutic targets via in silico tools 155
INVESTIGATING THE NR2F2 STRUCTURE FOR DRUG REPURPOSING 152
RESCUING P53 BY NEW TRANSLATIONAL READTHROUGH INDUCING DRUGS 151
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors 145
FTSJ1 INHIBITION AS A STRATEGY FOR NONSENSE MUTATION SUPPRESSION IN TP53: INTEGRATIVE COMPUTATIONAL AND EXPERIMENTAL ANALYSIS 144
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects 131
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis 128
Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies 126
Sulfonamide moiety as "molecular chimera" in the design of new drugs 124
Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics 124
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors 118
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 116
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 111
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity 107
Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation 106
Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test 106
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING 105
Beyond Nonsense: New Molecules as Precision Therapy for Rare Genetic Diseases 102
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors 94
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors 92
Treatment of Complex Regional Pain Syndrome (Crps): New Perspectives in the Use of Sulfonamides as Modulators of P2x Receptors 75
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome 71
Unveiling Novel Hybrids Quinazoline/Phenylsulfonylfuroxan Derivatives with Potent Multi-Anticancer Inhibition: DFT and In Silico Approach Combining 2D-QSAR, Molecular Docking, Dynamics Simulations, and ADMET Properties 70
Biophysical insights into the pathogenicity of rare genetic disease-associated proteins 67
Non-covalent immunoproteasome inhibitors: virtual screening and in vitro test on β1i /β5i subunits 63
Design, Synthesis, Characterization, in Vitro Biological Evaluation, and in Silico Investigation of 4-Substituted Arylidene Pyrazolones Through Docking, Molecular Dynamics Simulations, and DFT Studies 57
CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives 53
Docking in the Dark: Insights into Protein–Protein and Protein–Ligand Blind Docking 42
QSAR-Guided Design of Serotonin Transporter Inhibitors Supported by Molecular Docking and Biased Molecular Dynamics 8
Totale 4.709
Categoria #
all - tutte 14.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 6 23
2021/2022194 12 30 15 9 1 7 19 12 16 21 16 36
2022/2023351 30 38 9 29 63 55 22 25 28 5 20 27
2023/2024264 29 19 17 8 15 52 21 8 2 27 25 41
2024/20251.006 21 24 37 97 41 84 70 121 76 117 96 222
2025/20262.534 173 61 205 336 263 394 366 270 189 174 103 0
Totale 4.709